Adamantane

Adamantane

SCHEMBL870112

C1C2CC3CC1CC(C2)C3.N.N

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.43
LMNA P02545 2/20 0.33
SLC22A2 O15244 1/20 0.33
SLC22A1 O15245 1/20 0.33
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33
STAT6 P42226 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2A Q12879 1/20 0.33
GRIN2B Q13224 1/20 0.33
GRIN2C Q14957 1/20 0.33
GRIN3A Q8TCU5 1/20 0.33
SLC47A1 Q96FL8 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
POLB P06746 1/20 0.31
THRB P10828 1/20 0.31
BLM P54132 1/20 0.31
PMP22 Q01453 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adamantane SCHEMBL913610 1.00 CYP2C9 (0.43) CYP2C9LMNASLC22A2SLC22A1GRIN2D
Adamantane SCHEMBL28551331 0.94 CYP2C9 (0.40) CYP2C9LMNASLC22A2SLC22A1GRIN2D
Adamantane SCHEMBL317246 0.94 CYP2C9 (0.40) CYP2C9LMNASLC22A2SLC22A1GRIN2D
Adamantane SCHEMBL21433651 0.94 CYP2C9 (0.40) CYP2C9LMNASLC22A2SLC22A1GRIN2D
Adamantane SCHEMBL18065809 0.94 CYP2C9 (0.40) CYP2C9LMNASLC22A2SLC22A1GRIN2D
Adamantane SCHEMBL12761 0.93 CYP2C9 (0.46) CYP2C9LMNASLC22A2SLC22A1GRIN2D
Adamantane SCHEMBL1527414 0.93 CYP2C9 (0.46) CYP2C9LMNASLC22A2SLC22A1GRIN2D
Adamantane SCHEMBL29707714 0.93 CYP2C9 (0.46) CYP2C9LMNASLC22A2SLC22A1GRIN2D
Adamantane SCHEMBL9016497 0.93 CYP2C9 (0.46) CYP2C9LMNASLC22A2SLC22A1GRIN2D
Adamantane SCHEMBL7154373 0.88 CYP2C9 (0.38) CYP2C9LMNAPOLBTHRBBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119286207-B Toughened and modified PBT (polybutylene terephthalate) and processing method thereof 浙江长鸿生物材料有限公司 2025-05-09 CN claimed
CN-119236705-B High-selectivity roll film and application thereof 同舟纵横(厦门)流体技术有限公司 2025-04-29 CN claimed
CN-119793230-A High-performance composite solvent-resistant nanofiltration membrane with rigid twisted non-planar structure polyamide layer and preparation method thereof 中国海洋大学 2025-04-11 CN claimed
CN-119490749-A High-temperature-resistant anti-aging sealing gasket and preparation method thereof 慈溪埃弗龙密封件有限公司 2025-02-21 CN claimed
CN-119286207-A Toughened and modified PBT (polybutylene terephthalate) and processing method thereof 浙江长鸿生物材料有限公司 2025-01-10 CN claimed
CN-119236705-A High-selectivity roll film and application thereof 同舟纵横(厦门)流体技术有限公司 2025-01-03 CN claimed
EP-3122182-B1 AGROCHEMICAL OIL BASED CONCENTRATES CRODA INT PLC (GB) 2024-09-04 EP claimed
CN-118169263-A Cell surface proteome in-situ analysis method based on interaction of host and guest and without calibration 中国科学院大连化学物理研究所 2024-06-11 CN claimed
CN-111423584-B Preparation method of bismaleimide containing adamantane structure 沈阳化工大学 2023-03-24 CN claimed
CN-114685743-B Low-temperature epoxy resin curing agent and preparation method thereof 韦尔通(厦门)科技股份有限公司 2023-01-31 CN claimed
CN-105968355-B A kind of synthetic method of polyimides 万华化学集团股份有限公司 2018-12-07 CN claimed
US-9861100-B2 Agrochemical oil based concentrates CRODA INTERNATIONAL PLC (GB) 2018-01-09 US claimed
US-20170105411-A1 AGROCHEMICAL OIL BASED CONCENTRATES CRODA INTERNATIONAL PLC (GB) 2017-04-20 US claimed
EP-3122182-A1 AGROCHEMICAL OIL BASED CONCENTRATES Croda International PLC (GB) 2017-02-01 EP claimed
WO-2015145105-A1 AGROCHEMICAL OIL BASED CONCENTRATES CRODA INTERNATIONAL PLC (GB) 2015-10-01 WO claimed
WO-2010112946-A1 ADAMANTANE BISUREA DERIVATIVES, METHOD OF PREPARATION AND APPLICATION IN ANION SENSING RUDJER BOSKOVIC INSTITUTE (HR) 2010-10-07 WO claimed
EP-1353972-A2 NITROCELLULOSE-COMPATIBLE LAMINATING INK RESINS ARIZONA CHEMICAL COMPANY (US) 2003-10-22 EP claimed
US-20020002215-A1 Nitrocellulose-compatible laminating ink resins BANK OF AMERICA, N.A. 2002-01-03 US claimed
WO-2001090221-A2 NITROCELLULOSE-COMPATIBLE LAMINATING INK RESINS ARIZONA CHEMICAL COMPANY (US) 2001-11-29 WO claimed
US-6242509-B1 ESTER-TERMINATED DIMER ACID-BASED POLYAMIDE AND FUNGICIDE, HEMORRHOID OR WART TREATMENT AGENT, ANTI-ITCHING AGENT, ANTIBIOTIC OR TOPICAL ANALGESIC; CANDLES INTERNATIONAL PAPER COMPANY 2001-06-05 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170105411-A1 AGROCHEMICAL OIL BASED CONCENTRATES DGAT2, DGAT1, DLST CYP2C9 2487/4885LMNA 2667/4885SLC22A2 1567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.